Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Merck sees Oxytrol OTC as cushion against Rx patent expirations; Pfizer acquisitions boost consumer sales 16% in Q4; Latin America stands out for Mead Johnson.